Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth

[1]  E. Burchard,et al.  Ancestry and Genetic Associations with Bronchopulmonary Dysplasia in Preterm Infants , 2018, bioRxiv.

[2]  M. Segal,et al.  Antiinflammatory Effects of Budesonide in Human Fetal Lung. , 2016, American journal of respiratory cell and molecular biology.

[3]  J. Haines,et al.  Whole exome sequencing of extreme age-related macular degeneration phenotypes , 2016, Molecular vision.

[4]  G. Shaw,et al.  The genetic predisposition to bronchopulmonary dysplasia , 2016, Current opinion in pediatrics.

[5]  J. Padbury,et al.  Targeted Sequencing and Meta-Analysis of Preterm Birth , 2016, PloS one.

[6]  G. Hansmann,et al.  Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK , 2016, Heart.

[7]  Hua He,et al.  Csk/Src/EGFR signaling regulates migration of myofibroblasts and alveolarization. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[8]  F. Alkuraya,et al.  Exome-based case–control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy , 2016, Human Genetics.

[9]  Jinchuan Xing,et al.  Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility , 2016, Human Genomics.

[10]  B. Poindexter,et al.  Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. , 2015, Annals of the American Thoracic Society.

[11]  Davide Cittaro,et al.  Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[12]  N. Ambalavanan,et al.  Genetic predisposition to bronchopulmonary dysplasia. , 2015, Seminars in perinatology.

[13]  B. Poindexter,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[14]  G. Shaw,et al.  Exome Sequencing of Neonatal Blood Spots and the Identification of Genes Implicated in Bronchopulmonary Dysplasia. , 2015, American journal of respiratory and critical care medicine.

[15]  M. Rieder,et al.  Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis , 2015, PLoS genetics.

[16]  T. Mariani,et al.  Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States , 2015, BMC Pediatrics.

[17]  S. Bhattacharya,et al.  Integrated genomic analyses in bronchopulmonary dysplasia. , 2015, The Journal of pediatrics.

[18]  J. Ellenberg,et al.  Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach , 2015, Journal of Perinatology.

[19]  L. Doyle,et al.  An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. , 2014, The Journal of pediatrics.

[20]  T. Axenovich,et al.  FFBSKAT: Fast Family-Based Sequence Kernel Association Test , 2014, PloS one.

[21]  Clara-Cecilie Günther,et al.  Gene Expression Profiling in Preterm Infants: New Aspects of Bronchopulmonary Dysplasia Development , 2013, PloS one.

[22]  J. Witte,et al.  A Genome-Wide Association Study (GWAS) for Bronchopulmonary Dysplasia , 2013, Pediatrics.

[23]  Daniel J Schaid,et al.  Multiple Genetic Variant Association Testing by Collapsing and Kernel Methods With Pedigree or Population Structured Data , 2013, Genetic epidemiology.

[24]  Iuliana Ionita-Laza,et al.  Sequence kernel association tests for the combined effect of rare and common variants. , 2013, American journal of human genetics.

[25]  S. Bhattacharya,et al.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. , 2012, American journal of respiratory and critical care medicine.

[26]  G. Badger,et al.  Mortality and Neonatal Morbidity Among Infants 501 to 1500 Grams From 2000 to 2009 , 2012, Pediatrics.

[27]  M. Stephens,et al.  Genome-wide Efficient Mixed Model Analysis for Association Studies , 2012, Nature Genetics.

[28]  G. Shaw,et al.  Risk of Bronchopulmonary Dysplasia by Second Trimester Maternal Serum Levels of Alpha-fetoprotein, Human Chorionic Gonadotrophin, and Unconjugated Estriol , 2012, Pediatric Research.

[29]  C. Delacourt,et al.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. , 2011, American journal of respiratory and critical care medicine.

[30]  Chang Won Choi,et al.  Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia , 2011, Neonatology.

[31]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[32]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[33]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[34]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[35]  J. Crapo,et al.  Postnatal estradiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplasia. , 2009, American journal of respiratory and critical care medicine.

[36]  M. Sunday,et al.  Gastrin‐Releasing Peptide, Immune Responses, and Lung Disease , 2008, Annals of the New York Academy of Sciences.

[37]  K. Jang,et al.  Heritability of Bronchopulmonary Dysplasia, Defined According to the Consensus Statement of the National Institutes of Health , 2008, Pediatrics.

[38]  C. Dammann,et al.  ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[39]  D. McElhinney,et al.  Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.

[40]  M. Hallman,et al.  Early hypoadrenalism in premature infants at risk for bronchopulmonary dysplasia or death , 2007, Acta paediatrica.

[41]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[42]  L. Ment,et al.  Familial and Genetic Susceptibility to Major Neonatal Morbidities in Preterm Twins , 2006, Pediatrics.

[43]  J. Frangos,et al.  Strain‐induced fetal type II epithelial cell differentiation is mediated via cAMP‐PKA‐dependent signaling pathway , 2006, American journal of physiology. Lung cellular and molecular physiology.

[44]  K. Carraway,et al.  Role of Neuregulin-1β in the Developing Lung , 2003 .

[45]  A. Postle,et al.  Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[46]  J. Roberts,et al.  Differentiation of type II cells during explant culture of human fetal lung is accelerated by endogenous prostanoids and adenosine 3',5'-monophosphate. , 1991, Endocrinology.

[47]  S. Bhattacharya,et al.  Transcriptomic analysis of human lung development. , 2010, American journal of respiratory and critical care medicine.

[48]  K. Carraway,et al.  Role of neuregulin-1 beta in the developing lung. , 2003, American journal of respiratory and critical care medicine.